Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Cardinal Health Seeking to Acquire China Drug Distributors

publication date: Sep 27, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Cardinal Health, the US drug distribution company, is still hunting for M&A opportunities in China’s drug distribution sector. Late last year, Cardinal Health made its first purchase in China, paying a sizeable $470 million to acquire the China drug distribution business of Zuellig Pharma. In the future, Cardinal wants to combine organic growth with acquisitions to expand its presence in China. More details....

Stock Symbol: (NYSE: CAH)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors